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Abstract 26 
Arthroderma vanbreuseghemii has been identified molecularly as the causative agent of 27 
dermatophytosis in a flock of sheep. It is necessary to explore new treatment alternatives 28 
because antifungals are not approved for use on small ruminant animals in the European 29 
Union. Antimicrobial photodynamic therapy (aPDT) has been shown to be effective for the 30 
treatment of dermatophytosis in humans. It is based on the application of a photosensitizer 31 
such as methylene blue (MB) that is activated by visible light to generate reactive oxygen 32 
species that are cytotoxic to cells. The use of daylight to perform aPDT (aDL-PDT) avoids the 33 
requirement of specific equipment because it uses sunlight to activate the photosensitizer. The 34 
aim of our study is to determine the efficacy of aDL-PDT using a 1% MB solution to treat 35 
dermatophytosis caused by A. vanbreuseghemii in ewes. Two different topical protocols (1% 36 
MB solution spray applications once or twice a week) were assayed in two groups of five 37 
infected animals. Twenty-five infected sheep were untreated. All the sheep were exposed to 38 
sunlight every day for an approximate duration of 10 hours for a total of four weeks. At the 39 
end of the study, all the animals treated with aDL-PDT showed the same clinical response to 40 
both protocols. In contrast, the animals exposed only to sunlight required an additional two to 41 
four weeks before their infections resolved. 42 
Conclusion: aDL-PDT with 1% MB solution demonstrates efficacy, safety and efficiency in 43 
the treatment of dermatophytosis in sheep. 44 
 45 
1. Introduction 46 
Dermatophytosis (tinea or ringworm) is a skin disease caused by keratinophilic fungi 47 
belonging to the family Arthrodermataceae that includes genera Trichophyton, Microsporum 48 
and Epidermophyton (Borman and Summerbell, 2015). These generic names are historically 49 
applied to the asexual state of the fungi, and any dermatophyte capable of sexual reproduction 50 
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also has historical teleomorph names in the genus Arthroderma (Weitzman et al. 1986). In 51 
domestic ruminants, dermatophytosis is nearly exclusively caused by Trichophyton spp. 52 
(Rochette et al. 2003). The clinical signs are usually mild and active lesions which heal after 6 53 
to 16 weeks (Roberson et al. 2012) (Borman and Summerbell, 2015). However, 54 
dermatophytosis is present worldwide in cattle and sheep and can cause high economic losses 55 
in farms, is highly contagious and can have an impact on public health when a zoonotic 56 
mycotic species is involved (Rochette et al. 2003). 57 
We confirmed our diagnosis of dermatophytosis by isolating A. vanbreuseghemii in a culture. 58 
A presumptive diagnosis based on clinical signs and history is also generally acceptable 59 
because fungal contaminants and secondary bacterial infections often contaminate cultures 60 
(Borman and Summerbell, 2015). 61 
The most significant obstacle in the treatment of dermatophytosis is that specific antimycotic 62 
treatments, such as griseofulvin because of its accumulation in tissues and teratogenic effects, 63 
are banned from use in sheep and other food-producing animals in the European Community. 64 
Furthermore, topical treatments such as iodine 5% are not usually used because they dye the 65 
wool, last long, and their application is complicated. Enilconazole’s topical application is 66 
permitted in cattle, but is not approved for sheep. 67 
Photodynamic Therapy (PDT) is a technique that utilizes the reactive oxygen species (ROS) 68 
produced by non-toxic dye or photosensitizer (PS) molecules in the presence of visible light 69 
to destroy target cells (Buchholz and Walt. 2013). It was originally developed for the 70 
treatment of cancer, but it has been successfully employed in the treatment of infectious 71 
diseases, including fungal infections (Lyon et al. 2011) (Buchholz and Walt. 2013). However, 72 
the specific equipment required to perform the illuminations makes the therapy too 73 
complicated and expensive to be used in clinical veterinary. Daylight PDT (DL-PDT) is a new 74 
modality of PDT that uses sunlight to activate the PS instead of lamps. It has been shown to 75 
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be as effective as conventional PDT in treating actinic keratosis using methyl-aminolevulinate 76 
(MAL) as PS (Morton et al 2015). The use of daylight simplifies the PDT-procedure, makes it 77 
more efficient, (Wiegell et al.2012) and makes it possible to utilize for the treatment of 78 
animals, especially for superficial cutaneous infections. 79 
Methylene blue (MB), a well-known dye with a high ability to generate 1O2, has shown 80 
photodynamic activity against several infections, including dermatophytosis (Souza et al. 81 
2014). 82 
The aim of our study is to investigate the efficacy of MB-DL-PDT to treat dermatophytosis in 83 
sheep. 84 
 85 
2. Material and Methods 86 
2.1. Type of study and farm characteristics 87 
We conducted an experimental, controlled trial, on a privately owned flock of domestic 88 
sheep. We used clinical practice methods in our study, prioritised interfering only minimally 89 
with flock management, and took care not to cause additional stress to the animals. The farm 90 
is located in the province of Zaragoza, Spain. The animals were kept in communal yards with 91 
uncovered areas, and without any supplementary light. At night, the sheep were housed in 92 
pens with adequate indoor and outdoor space. The flock had no history of antifungal or 93 
antibacterial therapy during the months preceding our trial. 94 
2.2. Study group 95 
A total of 35 replacement ewe lambs clinically diagnosed with dermatophytosis were included 96 
in the study. All the lambs presented with scaling, crusts, annular plaques, and hair loss. The 97 
main clinical, dermatological patterns were those of non-pruritic, exfoliative dermatitis with 98 
focal-multifocal alopecias. The selected infected lambs were divided in two groups. One 99 
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group of 10 ewes with 14 active lesions was selected for treatment application. The other 100 
group of 25 infected animals was not treated and was used as the control group. 101 
2.3. Specimen collection, microscopy examination and culture 102 
We discovered that the lesion samples taken from the first sheep included in our study were 103 
systematically contaminated, but we could not identify the etiological agent. Therefore, for all 104 
subsequent samples, the area was cleaned with 70% alcohol, and the first scraping was 105 
discarded. We collected hair, wool, and skin scrapings from the 10 infected ruminants in the 106 
treatment group in this manner. The advancing border of the lesion was scraped with the blunt 107 
edge of a sterile, disposable scalpel; hairs and scales were plucked with sterile tweezers; dry 108 
and sterile containers were used for sample transport. 109 
The hair plucking, skin scrapings, and coat brushings were treated with KOH 20 % mixed 110 
with equal parts of Calcofluor-white (Robinson and Padhye, 1988) (Borman and Summerbell, 111 
2015) for direct microscopy examination. The skin scrapings were cultured on Sabouraud 112 
dextrose agar medium with chloramphenicol, (Oxoid, Basic stock, UK) dermatophyte test 113 
medium containing cycloheximide, (Oxoid, Basic stock, UK) and potato dextrose agar 114 
(Oxoid, Basic stock, UK) with of 50 mg/L chloramphenicol. 115 
2.4. Molecular identification 116 
To confirm laboratory diagnosis, a sequence-based identification was performed for two 117 
representative isolates, FMR 14361 (= 6334 - TA) and FMR 14362, (= 6455 - TA) from 118 
different animal specimens selected at random because all the samples seemed to be the same 119 
macroscopically and microscopically. 120 
The total genomic DNA was extracted from fresh mycelia harvested from colonies grown on 121 
the PDA for seven days at 25°C using the FastPrep kit (MP Biomedicals, Santa Ana, CA) 122 
according to the manufacturer’s protocol. The DNA was quantified using a Nanodrop 3000 123 
apparatus (Thermo Scientific, Madrid, Spain). A region spanning the internal transcribed 124 
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spacer 1 (ITS1) and ITS2 and the 5.8 S gene of the ribosomal DNA (rDNA) was amplified 125 
using the primer pairs ITS4 and ITS5 (White et al., 1990). The amplified products were 126 
purified with the Diffinity RapidTip purification system (Sigma-Aldrich, St. Louis, MO) and 127 
stored at -20°C until sequencing. The sequencing was performed in both directions, with the 128 
same primer pair as used for amplification, at Macrogen Europe (Macrogen Inc., Amsterdam, 129 
The Netherlands). The consensus sequences were obtained using SeqMan version 7.0.0 130 
(DNAStar Lasergene, Madison, WI). 131 
The obtained sequences were compared for identity against reference sequence materials 132 
available in several public databases i.e., NCBI BLAST (www.ncbi.nlm.nih.gov), the ISHAM 133 
database (http://its.mycologylab.org), and the CBS Pairwise sequence alignment database 134 
(www.cbs.knaw.nl). 135 
2.5. Clinical treatment protocols 136 
Stock MB (Sigma-Aldrich Corporation, Steinheim, Germany) solution was prepared in 137 
distilled water and diluted with bidistilled water to the desired concentration 1:100 MB (10 g 138 
dissolved in one litre of water, sterilization at 121 °C). The solutions were prepared and 139 
handled under light-restricted conditions. 140 
A solution of MB 1% was sprayed on the fourteen lesions of the infected sheep of the 141 
treatment group for a total of four weeks. These lesions were completely covered in MB, 142 
seven of them once, and seven lesions twice a week. Prior to MB application, three lesions 143 
from the former treatment group (once a week) were cleaned by removing skin scales with a 144 
scalpel blade before applying the MB, whereas on the remaining four lesions, the MB was 145 
sprayed directly. We also followed this protocol for the twice a week group. After MB 146 
application, the sheep were exposed to direct sun all morning and part of the afternoon, 147 
approximately 10 hours a day. The 25 ewes of the control group were exposed to the same 148 
protocol except the MB application. 149 
Page 7 of 14 
 
The primary efficacy end point was the clinical improvement, monitored through photographs 150 
taken twice a week. The whole farm was under surveillance during a follow-up period of 10 151 
weeks. 152 
 153 
3. Results 154 
Seven samples taken from the 10 sheep selected to test the treatment with MB-aDL-PDT 155 
proved positive  (fungal growth) through plate culture, and six samples were positive 156 
(visualization of fungi) through direct microscopic examination prior to treatment when we 157 
were verifying the pathogen. Our results are shows in Table 1. The causal agent observed was 158 
A. vanbreuseghemii. It was determined through plate culture, as well as direct microscopic 159 
examination from samples taken from four ewes. The samples from the SN-2 TA sheep were 160 
the only double negative. The negative samples were retained for four weeks before we 161 
discarded them as negative. The isolates 6334 TA and 6455 TA A. vanbreuseghemii were 162 
selected from the cultures and identified by molecular techniques. 163 
The analysis of the ITS sequences of the two isolates, FMR 14361 (= 6334 TA) and FMR 164 
14362 (= 6455 TA), yielded high degrees of identity (>99%) and coverage, (>99%) with 165 
several reference sequences of A. vanbreuseghemii including the type strain of its anamorph, 166 
Trichophyton interdigitale CBS 428.63 (GenBank sequence accession number JX122216). 167 
Thus, we conclude that it is unambiguously assigned to this species. The numbers of the two 168 
dermatophyte strain sequences deposited in GenBank are KT963002 for FMR 14361 169 
(=6334TA) and KT963003 for FMR 14362 (=6455 TA). 170 
The 14 treated skin lesions of the 10 animals gradually improved during the period of MB-171 
aDL-PDT application, and hair regrowth started (Figure 1). No relapse of the disease was 172 
observed during a follow-up period of ten weeks, and no adverse effects were observed at any 173 
time. No differences were detected from applying the PS once or twice a week (Figure 2). 174 
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Cleaning the lesions before the spray application of the PS did not affect the efficacy of the 175 
treatment. 176 
All the sheep from the control group took between six to eight weeks to reach complete 177 
clinical resolution, which was two to four weeks more than the group treated with aDL-PDT 178 
 179 
4. Discussion 180 
Our study demonstrates the efficacy of aDL-PDT using 1% MB solution for the treatment of 181 
dermatophytosis in ewes caused by A. vanbreuseghemii. The results obtained after four weeks 182 
of treatment are promising; the skin lesions showed a significant reduction upon physical 183 
examination after two weeks. Thereby, according to our results, one application a week for 184 
four weeks, or possibly two weeks, would be an adequate therapeutic dose because there were 185 
no differences between sheep treated once or twice a week. 186 
The differential diagnosis of dermatophytosis in ewes has to be performed when other skin 187 
diseases are suspected, especially scabies, urticaria, bacterial and viral infections (e.g. 188 
staphylococcal folliculitis or contagious viral pustular dermatitis), seborrheic dermatitis, and 189 
zinc-responsive dermatitis. Clinical suspicion is enough to start the treatment because 190 
microbiological diagnosis is difficult due to the enormous amounts of saprophytes and 191 
opportunistic agents, especially fungal spores and conidia, and bacteria present on the skin of 192 
the sheep. Therefore, samples must be taken from the edges lesions after cleaning the area and 193 
removing the first flakes of skin. We discovered that we had to change our initial sampling 194 
methodology in order to avoid contaminants. For isolation cultures, the addition of 195 
antibacterial substances and cycloheximide to the medium in order to inhibit the growth of 196 
contaminating fungi, is highly recommended (Borman and Summerbell, 2015). Two 197 
diagnostic laboratories are involved in our study, and in only one of them that has ISO 15189 198 
and used media with inhibitory selective substances, the causative agent was isolated. It is 199 
Page 9 of 14 
 
possible that dermatophyte infections are difficult to diagnose because the fungi are relatively 200 
protected within hair shafts and hair follicles (Borman and Summerbell, 2015). 201 
The isolates did not produce conidia, which makes morphological identification impossible; 202 
therefore, molecular identification is helpful. The PCR amplification and sequencing of ITS-1 203 
has proven effective for dermatophyte identification (Li et al. 2008). The recommendation of 204 
standard DNA barcodes (Summerbell 2007) is in progress, and the ITS-1 region is emerging 205 
as a key panfungal region for the molecular identification of moulds, including dermatophytes 206 
(Balajee 2008, Li et al. 2008). 207 
With regard to the molecular identification of the causative agent A. vanbreuseghemii, to our 208 
knowledge, this is the first confirmed case of this kind of infection in sheep. This is probably 209 
due to the fact that it can be confused with other zoophilic species with similar clinical 210 
manifestations, and when it is isolated in culture, it is often misidentified due to its 211 
phenotypical similarity with T. verrucosum. 212 
To objectively assess the efficacy and effectiveness of the MB, we should compare it with the 213 
progression of the infection without treatment, and with the standard treatment of ringworm, 214 
even though there is no specific treatment protocol for small ruminants. The untreated sheep 215 
usually self-heal, (Roberson et al. 2012) (Borman and Summerbell, 2015) although the 216 
duration of healing is longer, about two to four weeks longer, than for those animals treated 217 
with aDL-PDT. With respect to antifungals, enilconazole should also be applied topically, 218 
with a frequency range of once a week to three times per week, depending on the severity of 219 
the lesions. The treatment duration is usually two weeks, and the lesions start improving 220 
between two and four weeks after the last application, depending on the severity of the lesions 221 
(Rochette et al. 2003). Conventional treatment therefore, may require more applications, and 222 
the lesions do not improve in less time than with aDL-PDT. Furthermore, MB is not 223 
associated with residue risks, and its blue stain on the skin, hair and wool completely 224 
Page 10 of 14 
 
disappeared after the therapy concluded. This fact is very important because sheep are used 225 
for meat and they are subject to strict controls against residues to avoid health risks. 226 
Different PSs have been shown to effectively photoinactivate different genera of 227 
dermatophytes such as hypericin (Paz-Cristobal et al. 2014) and Toluidine Blue O in vitro 228 
(Mehra et al. 2015). PDT with MAL has been successfully employed against superficial 229 
fungal infections in humans, including dermatophytoses, in several clinical studies (Lyon et 230 
al. 2011) (Gilaberte et al. 2011). Recently, Souza et al. demonstrated the efficacy of PDT 231 
using 2% MB to treat severe distal and lateral subungual toenail onychomycosis (Souza 232 
2014). However, to our knowledge, there are neither studies using MB-PDT to treat 233 
dermatophyte infections in animals—it has been only explored in cases of bovine mastitis, 234 
(Sellera et al. 2016a) and in cases of caseous lymphadenitis abscesses in sheep (Sellera et al. 235 
2016b)—nor studies exploring the efficacy of aDL-PDT using MB in humans or in animals. 236 
Furthermore, the use of MB-aDL-PDT to treat ringworm in sheep is of note because it is 237 
effective and safe for humans, as well as inexpensive and easy to apply on sheep which are 238 
usually exposed to sunlight. 239 
Some of the limitations of our study are (1) the sample size was small and therefore our 240 
results should be confirmed in larger studies; (2) we did not have another control group 241 
exposed only to MB; therefore, the effect of MB without the catalyst of sunlight on healing 242 
ringworms could not be excluded. We also did not have a group of healthy ewes treated with 243 
MB; and (3) microbiological samples were not taken from the control group; they were only 244 
subjected to the clinical follow up, and their microbiological cure was not confirmed for the 245 
MB groups. 246 
 247 
5. Conclusion 248 
Page 11 of 14 
 
In our study, A. vanbreuseghemii was identified as a causative agent of dermatophytosis in a 249 
flock of sheep. According to our results, MB-aDL-PDT could be a promising treatment for 250 
ringworm, especially in those cases caused by this agent. Whether this treatment can be used 251 
in veterinary clinics, or for other kinds of superficial infections, or on other species of animals 252 
is yet to be determined. 253 
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Table 1: Microbiological diagnosis of the ten sheep that constitute the treated group: Plate 322 
cultures + KOH determination. 323 
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 324 
Figure 1: Progress of the lesions in the 6036 –TA sheep. Clinical treatment protocol: the 325 
lesion was completely covered in MB twice a week, the MB 1% was sprayed directly, this 326 
lesion was not cleaned by removing skin scales with a scalpel blade before applying the MB. 327 
The top image shows the lesion at the start of progress –time 0- (A), the image of the medium 328 
shows the lesion at 1 week of treatment (B). and the bottom image shows the lesion at 3 week 329 
of treatment (C). 330 
Figure 2: Examples of the lesions in the 6648 –TA sheep treated by applying the PS once a 331 
week (A) and the SN2 –TA sheep treated twice (B). The top image shows the lesion at the 332 
start of progress, and the bottom image shows the end of treatment. 333 







Figure 2A and 2B
SN2  - TA 
SN2  - TA 
B 
ID samples Culture KOH result 
SN-1 TA A.vanbreuseghemii Yes 
6419 TA negative  Yes  
6181 TA A.vanbreuseghemii Yes  
6110 TA A.vanbreuseghemii Yes  
6413 TA A.vanbreuseghemii No 
6648 TA negative  Yes  
6334 TA A.vanbreuseghemii No 
SN-2 TA negative  No 
6455 TA A.vanbreuseghemii Yes  
6036 TA A.vanbreuseghemii No 
Table 1: Microbiological diagnosis of the ten sheep that constitute the treated group: 
Plate cultures + KOH determination. 
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